Biogen's HQ plans change, thanks to early Tecfidera success

Tools

What happens when a new drug comes charging out of the launch gate? For Biogen Idec ($BIIB), it means a rethink of its real estate plans. Its fast-growing staff won't all fit in the new headquarters under construction in Cambridge, MA. Report

Filed Under